Literature DB >> 18524495

Is euthyroid sick syndrome a defensive mechanism against oxidative stress?

N Selvaraj1, Zachariah Bobby, M G Sridhar.   

Abstract

The body has a hierarchy of defence strategies to deal with oxidative stress. Among these arrays of defence mechanisms, the over expression and increased activity of glutathione peroxidases has been suggested as the first line of defence. The two main cofactors required for glutathione peroxidase activity are selenium and reduced glutathione. These two factors have been shown to be required for the deiodinase activity also. In vitro and in vivo studies have shown that oxidative stress decreases the activity of deiodinase. Thus, a decrease in deiodinase activity would facilitate the use of these cofactors by glutathione peroxidase in combating oxidative stress. Lowering of serum T3 is generally regarded as a valuable calorie-sparing economy. A decreased metabolic state of the cells as found in euthyroid sick syndrome indicates a decreased free radical generation from the mitochondria. For this reason, euthyroid sick syndrome could be considered as a physiological mechanism activated in response to oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524495     DOI: 10.1016/j.mehy.2007.11.019

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  The relationship between inflammatory factors, oxidative stress and DIO-1 concentration in patients with chronic renal failure accompanied with or without euthyroid sick syndrome.

Authors:  Shu-Lan Qin; Qi He; Ling Hu; Chun-Yan He; Li-Cheng Gao; Charlotte Aimee Young; Juan Chen; Cheng-Fang Jiang; Xiang-Feng Luo; Ying Zhou; Xia Sheng; Zhi-Hong Li; Mei-Ling Chen; Gaosi Xu
Journal:  J Int Med Res       Date:  2018-08-28       Impact factor: 1.671

Review 2.  Sepsis as a Pan-Endocrine Illness-Endocrine Disorders in Septic Patients.

Authors:  Weronika Wasyluk; Martyna Wasyluk; Agnieszka Zwolak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.